Promiscuous T-cell recognition of a rubella capsid protein epitope restricted by DRB1*0403 and DRB1*0901 molecules sharing an HLA DR supertype

被引:15
作者
Ou, DW
Mitchell, LA
Décarie, D
Tingle, AJ
Nepom, GT
机构
[1] Univ British Columbia, Fac Med, Dept Paediat, Vancouver, BC V5Z 4H4, Canada
[2] Univ British Columbia, Fac Med, Dept Pathol, Vancouver, BC V5Z 4H4, Canada
[3] Virginia Mason Res Ctr, Seattle, WA 98101 USA
关键词
D O I
10.1016/S0198-8859(98)00006-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Two T cell clones derived from different donors with HLA-DRB1*0403 or DRB1*0901 phenotype recognize a rubella capsid peptide, C(265-273) in the context of several different HLA-DR molecules in addition to DRB *0403 and DRB1*0901. All DR molecules restricting the T-cell clones have in common residues, R or Q at position beta 70, R at position beta 71, and E at position beta 74 in pocket '4' of the DR peptide binding groove, suggesting that a DR subregion structure or supertype, "Q/RRE" underlies the promiscuous T-cell recognition of this peptide. Single amino acid substituted analogs of peptide C(263-275) at anchor position 4 for natural residue R were tested for their ability to induce clonal T-cell cytotoxic responses. The results indicated that a positively charged residue, R or K, was required for T-cell recognition, suggesting a possible mechanism of electrostatic interactions between the negatively charged residue E at position beta 74 of these DR molecules and the positively charged residue at anchor position 4 of the peptide in T-cell recognition. (C) American Society for Histocompatibility and Immunogenetics, 1998. Published by Elsevier Science Inc.
引用
收藏
页码:149 / 157
页数:9
相关论文
共 34 条
[1]  
BRODSKY FM, 1982, J IMMUNOL, V128, P129
[2]   Searching for pathogenic epitopes in thyroglobulin: Parameters and caveats [J].
Carayanniotis, G ;
Rao, VP .
IMMUNOLOGY TODAY, 1997, 18 (02) :83-88
[3]   NUCLEOTIDE-SEQUENCE AND INVITRO EXPRESSION OF RUBELLA-VIRUS 24S SUBGENOMIC MESSENGER-RNA ENCODING THE STRUCTURAL PROTEIN-E1, PROTEIN-E2 AND PROTEIN-C [J].
CLARKE, DM ;
LOO, TW ;
HUI, I ;
CHONG, P ;
GILLAM, S .
NUCLEIC ACIDS RESEARCH, 1987, 15 (07) :3041-3057
[4]   POCKET-4 OF THE HLA-DR(ALPHA,BETA-1-ASTERISK-0401) MOLECULE IS A MAJOR DETERMINANT OF T-CELL RECOGNITION OF PEPTIDE [J].
FU, XT ;
BONO, CP ;
WOULFE, SL ;
SWEARINGEN, C ;
SUMMERS, NL ;
SINIGAGLIA, F ;
SETTE, A ;
SCHWARTZ, BD ;
KARR, RW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (03) :915-926
[5]   Identification of HLA-DR9 (DRB1*0901)-binding peptide motifs using a phage fUSE5 random peptide library [J].
Fujisao, S ;
Matsushita, S ;
Nishi, T ;
Nishimura, Y .
HUMAN IMMUNOLOGY, 1996, 45 (02) :131-136
[6]   STRUCTURAL-ANALYSIS OF A HUMAN I-A HOMOLOG USING A MONOCLONAL-ANTIBODY THAT RECOGNIZES AN MB3-LIKE SPECIFICITY [J].
GILES, RC ;
NUNEZ, G ;
HURLEY, CK ;
NUNEZROLDAN, A ;
WINCHESTER, R ;
STASTNY, P ;
CAPRA, JD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 157 (05) :1461-1470
[7]   PEPTIDE BINDING-SPECIFICITY OF HLA-DR4 MOLECULES - CORRELATION WITH RHEUMATOID-ARTHRITIS ASSOCIATION [J].
HAMMER, J ;
GALLAZZI, F ;
BONO, E ;
KARR, RW ;
GUENOT, J ;
VALSASNINI, P ;
NAGY, ZA ;
SINIGAGLIA, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (05) :1847-1855
[8]   STRONG ASSOCIATION BETWEEN HLA DRW9 AND HASHIMOTOS-THYROIDITIS IN SOUTHERN CHINESE [J].
HAWKINS, BR ;
LAM, KSL ;
MA, JTC ;
WANG, C ;
YEUNG, RTT .
ACTA ENDOCRINOLOGICA, 1987, 114 (04) :543-546
[9]   STRUCTURAL REQUIREMENTS FOR RECOGNITION OF THE HLA-DW14 CLASS-II EPITOPE - A KEY HLA DETERMINANT ASSOCIATED WITH RHEUMATOID-ARTHRITIS [J].
HIRAIWA, A ;
YAMANAKA, K ;
KWOK, WW ;
MICKELSON, EM ;
MASEWICZ, S ;
HANSEN, JA ;
RADKA, SF ;
NEPOM, GT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (20) :8051-8055
[10]   COORDINATE DEFECTS IN HUMAN HISTOCOMPATIBILITY LEUKOCYTE ANTIGEN CLASS-II EXPRESSION AND ANTIGEN PRESENTATION IN BARE LYMPHOCYTE SYNDROME [J].
KOVATS, S ;
DROVER, S ;
MARSHALL, WH ;
FREED, D ;
WHITELEY, PE ;
NEPOM, GT ;
BLUM, JS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (06) :2017-2022